Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.30    0.30 (0.07%)
Bid:
428.60
Ask:
428.90
Spread: 0.30 (0.07%)
Market Cap: £10.80b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q3 Trading Update

5 Nov 2015 07:00

RNS Number : 6149E
Rentokil Initial PLC
05 November 2015
 



  

RENTOKIL INITIAL PLC (RTO)

THIRD QUARTER (Q3) TRADING UPDATE

5 November 2015

 

Results

Q3 2015

Growth

YTD 2015

Growth

£m

AER

AER

CER

AER

AER

CER

Revenue

438.0

(0.4%)

4.1%

1,293.3

-

4.3%

Revenue - ongoing operations1

436.2

0.3%

4.8%

1,287.2

0.7%

5.1%

 

 

Overview (CER)Revenue from ongoing operations increased by 4.8% in the quarter. Q3 organic revenue growth was in line with the second quarter at 1.4% with 3.4% growth from acquisitions. Growth in the Emerging (+11.1%) and Growth (+9.3%) quadrants was strong, with revenue in the Protect and Enhance (-1.4%) and Manage for Value (-4.7%) quadrants down on last year. Revenue from ongoing operations for the nine months ended 30 September 2015 ("year-to-date") increased by 5.1% with organic growth of 1.7% and 3.4% from acquisitions.

Performance continues to be strong in the UK, North America, Asia, Pacific and Latin America driven by continued strong growth in pest control. While conditions remain difficult in France and the Netherlands, year-to-date ongoing revenue in the Europe region is in line with last year.

Cash flowYear-to-date operating and free cash flow are ahead of the prior year and we are confident of delivering free cash flow for the year in excess of £100m.

M&AIn Q3 we acquired five businesses, all in pest control in our Emerging and Growth quadrants. Combined annual revenues of the businesses acquired totalled £17m in the 12 months immediately prior to acquisition. Year-to-date we have acquired 19 businesses with combined annual revenues of £38m. As previously announced our acquisition of The Steritech Group Inc completed on 2nd October and the process of integration is underway and on track.

Commenting on trading in Q3, Andy Ransom, CEO of Rentokil Initial plc, said:"We continue to execute our strategy at pace with the recent acquisition of Steritech providing us with a high quality business with national scale in a key growth market. The performance in the majority of the group continues to be strong although trading in Europe, France in particular, remains challenging. Our guidance for the full year is unchanged."

 

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

01276 536585 / 07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

John Sunnucks

Bell Pottinger

0203 772 2549

 

 

 

AER - actual exchange rates; CER - constant 2014 exchange rates

 

1ongoing revenue excludes the financial performance of disposed and closed businesses but includes results from acquisitions

 

This announcement contains statements that are, or may be, forward-looking regarding the group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMMGMNDRGKZM
Date   Source Headline
23rd Jan 20153:56 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSRentokil Initial acquisitions
6th Jan 20154:43 pmRNSDirectorate Change
3rd Dec 201412:25 pmRNSChange to PDMR details
26th Nov 20145:50 pmRNSHolding(s) in Company
24th Nov 20144:03 pmRNSHolding(s) in Company
7th Nov 20147:00 amRNSQ3 Interim Management Statement
24th Oct 201410:33 amRNSHolding(s) in Company
15th Oct 20141:33 pmRNSHolding(s) in Company
13th Oct 201411:33 amRNSHolding(s) in Company
11th Sep 20141:23 pmRNSHolding(s) in Company
1st Aug 20147:00 amRNSHalf Yearly Report
30th Jul 20147:00 amRNSCompany Secretary Change
25th Jul 20142:14 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSDirectorate Change
3rd Jul 20145:00 pmRNSHolding(s) in Company
18th Jun 201410:18 amRNSHolding(s) in Company
6th Jun 20144:45 pmRNSHolding(s) in Company
3rd Jun 201410:17 amRNSTotal Voting Rights
23rd May 20145:03 pmRNSDirector/PDMR Shareholding
21st May 20147:00 amRNSDirector/PDMR Shareholding
15th May 201412:12 pmRNSAGM Statement
2nd May 20147:00 amRNS1st Quarter Results
22nd Apr 20149:51 amRNSHolding(s) in Company
11th Apr 201411:41 amRNSPublication of 2013 Annual Report & Board Changes
3rd Apr 20144:52 pmRNSHolding(s) in Company
1st Apr 20145:13 pmRNSDirector/PDMR Shareholding
18th Mar 20144:28 pmRNSHolding(s) in Company
18th Mar 20142:12 pmRNSHolding(s) in Company
18th Mar 20147:00 amRNSCompletion of sale of Initial Facilities
14th Mar 201410:56 amRNSHolding(s) in Company
13th Mar 20145:16 pmRNSHolding(s) in Company
11th Mar 20143:59 pmRNSHolding(s) in Company
10th Mar 201412:22 pmRNSHolding(s) in Company
10th Mar 201410:57 amRNSHolding(s) in Company
5th Mar 20147:00 amRNSAcquisition
3rd Mar 20143:02 pmRNSHolding(s) in Company
28th Feb 20147:02 amRNSSale of Initial Facilities
28th Feb 20147:02 amRNSPreliminary Results 31.12.13 and disposal
31st Jan 20144:13 pmRNSHolding(s) in Company
24th Jan 20144:18 pmRNSHead Office Location
23rd Jan 20145:53 pmRNSChange to Director's details
20th Dec 20137:01 amRNSDisposal of Pest Business
20th Dec 20137:00 amRNSAcquisition
2nd Dec 201310:00 amRNSHolding(s) in Company
21st Nov 20135:30 pmRNSTotal Voting Rights
15th Nov 20133:41 pmRNSHolding(s) in Company
13th Nov 20139:58 amRNSHolding(s) in Company
8th Nov 20137:00 amRNSInterim Management Statement
5th Nov 201310:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.